Year |
Citation |
Score |
2014 |
Damiano M, Gautier CA, Bulteau AL, Ferrando-Miguel R, Gouarne C, Paoli MG, Pruss R, Auchère F, L'Hermitte-Stead C, Bouillaud F, Brice A, Corti O, Lombès A. Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice. Plos One. 9: e99898. PMID 24959870 DOI: 10.1371/journal.pone.0099898 |
0.451 |
|
2014 |
Buhlman L, Damiano M, Bertolin G, Ferrando-Miguel R, Lombès A, Brice A, Corti O. Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance. Biochimica Et Biophysica Acta. 1843: 2012-26. PMID 24878071 DOI: 10.1016/J.Bbamcr.2014.05.012 |
0.393 |
|
2013 |
Damiano M, Diguet E, Malgorn C, D'Aurelio M, Galvan L, Petit F, Benhaim L, Guillermier M, Houitte D, Dufour N, Hantraye P, Canals JM, Alberch J, Delzescaux T, Déglon N, et al. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics. 22: 3869-82. PMID 23720495 DOI: 10.1093/Hmg/Ddt242 |
0.581 |
|
2011 |
Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R, Sporn M, Beal MF, Kiaei M. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radical Biology & Medicine. 51: 88-96. PMID 21457778 DOI: 10.1016/J.Freeradbiomed.2011.03.027 |
0.57 |
|
2010 |
Damiano M, Galvan L, Déglon N, Brouillet E. Mitochondria in Huntington's disease. Biochimica Et Biophysica Acta. 1802: 52-61. PMID 19682570 DOI: 10.1016/J.Bbadis.2009.07.012 |
0.607 |
|
2009 |
Magrané J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Human Molecular Genetics. 18: 4552-64. PMID 19779023 DOI: 10.1093/Hmg/Ddp421 |
0.501 |
|
2006 |
Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF. Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 98: 1141-8. PMID 16895581 DOI: 10.1111/J.1471-4159.2006.04018.X |
0.609 |
|
2006 |
Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, Flint Beal M, Manfredi G. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. Journal of Neurochemistry. 96: 1349-61. PMID 16478527 DOI: 10.1111/J.1471-4159.2006.03619.X |
0.536 |
|
Show low-probability matches. |